Tech / Ars Technica ·
The FDA wants to pull its approval of a drug. It’s not so easy.
October 31, 2026 at 11:02 AM · Source: Ars Technica
The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
This story was first reported by Ars Technica.
Read the full story ↗
